News – Serum Institute of India Makes Strategic Investment in IntegriMedical, India’s First Needle-Free Injection System (N-FIS) Technology
With this investment, SII will acquire 20% stake in IntegriMedical. The investment by SII in IntegriMedical is expected to accelerate the development and commercialization of......